Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinence

Diseases of the Colon and Rectum
E M AdangC G Baeten

Abstract

This study evaluates the cost-effectiveness of dynamic graciloplasty for intractable fecal incontinence. The costs and effects of dynamic graciloplasty were measured in a prospective, longitudinal study and in a clinical trial. Forty-three patients with intractable fecal incontinence were evaluated before and after dynamic graciloplasty. Costs were obtained from the hospital information system and from patient-oriented questionnaires. We compared the costs of a dynamic graciloplasty with the costs of a colostomy. Colostomy costs were evaluated using a group of seven patients who had a stoma in place for incontinence for several years. Sensitivity analyses were included. Total direct costs of lifelong dynamic graciloplasty were $31,733 (United States dollars), costs of lifelong conventional treatment were $12,180 (United States), and costs of colostomy, including lifelong stoma care, were $71,576 (United States). The clinical success rate of dynamic graciloplasty was 74 percent. Quality of life after successful dynamic graciloplasty was better than with conventional treatment. We found that dynamic graciloplasty was more expensive than conventional treatment but resulted in a significantly higher quality of life. Stoma treatment...Continue Reading

References

Jan 1, 1975·Psychotherapy and Psychosomatics·M WirschingG Herrmann
Apr 9, 1992·The New England Journal of Medicine·R D MadoffP F Caushaj
Dec 1, 1985·Diseases of the Colon and Rectum·G La MonicaV Ventafridda
Aug 14, 1971·British Medical Journal·H B DevlinM Griffin
Aug 1, 1983·The British Journal of Surgery·N S Williams, D Johnston
Apr 1, 1995·Diseases of the Colon and Rectum·M A SprangersA te Velde
Jun 15, 1995·The New England Journal of Medicine·C G BaetenP B Soeters
Oct 27, 1998·Diseases of the Colon and Rectum·R NelsonV Jesudason
Jan 1, 1965·Archives of General Psychiatry·W W ZUNG

❮ Previous
Next ❯

Citations

Sep 1, 2003·Environmental Health and Preventive Medicine·Gino C MatibagHiko Tamashiro
Jul 20, 2004·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·J Braun, S Willis
Aug 10, 2006·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·O RuthmannH J Schrag
Aug 8, 2001·The British Journal of Surgery·A J MaloufM A Kamm
Feb 23, 1999·The British Journal of Surgery·I SielezneffS Douglas
Feb 1, 2005·Clinics in Colon and Rectal Surgery·Susan M Cera, Steven D Wexner
Nov 4, 2004·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M J ThorntonD W King
Nov 17, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·E K TanP P Tekkis
Jan 30, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·G F GiannakopoulosM A Cuesta
Aug 15, 2000·Gut·M R Borgaonkar, E J Irvine
Mar 10, 2010·Regenerative Medicine·Hutan AshrafianThanos Athanasiou
Apr 25, 2014·Gastroenterology Report·Goran Barišić, Zoran Krivokapić
Jun 7, 2006·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy· Lirici Hüscher
Oct 9, 2003·Alimentary Pharmacology & Therapeutics·M Delvaux
Nov 23, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Michelle J Thornton, David Z Lubowski
Oct 6, 2006·The British Journal of Surgery·F H HetzerN Demartines
Apr 28, 2007·International Journal of Surgery·K S GurusamyH Benziger
Dec 18, 2001·Microsurgery·C G BaetenM J Rongen
Jun 7, 2003·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M J RongenC G Baeten
Aug 17, 2004·The American Journal of Gastroenterology·Satish S C Rao, UNKNOWN American College of Gastroenterology Practice Parameters Committee
Dec 12, 2003·Diseases of the Colon and Rectum·Roel BakxJ Jan B van Lanschot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.